{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:18:08Z","timestamp":1773292688690,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2003]]},"DOI":"10.1078\/0171-2985-00215","type":"journal-article","created":{"date-parts":[[2005,8,18]],"date-time":"2005-08-18T08:36:58Z","timestamp":1124354218000},"page":"23-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome"],"prefix":"10.1078","volume":"207","author":[{"given":"Jose D.","family":"Alves","sequence":"first","affiliation":[]},{"given":"Paul R.J.","family":"Ames","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1078\/0171-2985-00215_bib1","series-title":"Autoimmune Rheumatic Diseases","first-page":"56","article-title":"Systemic Lupus erythemtosus","author":"Morrow","year":"1999"},{"key":"10.1078\/0171-2985-00215_bib2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","article-title":"Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1078\/0171-2985-00215_bib3","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes","year":"1986","journal-title":"J. Rheumatology"},{"key":"10.1078\/0171-2985-00215_bib4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood.V66.5.1086.1086","article-title":"Beta2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway","volume":"66","author":"Schousboe","year":"1985","journal-title":"Blood"},{"key":"10.1078\/0171-2985-00215_bib5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0024-3205(01)01164-X","article-title":"Evidence for inhibition of low density lipoprotein oxidation and cholesterol accumulation by apolipoprotein H (beta2-glycoprotein I)","volume":"69","author":"Lin","year":"2001","journal-title":"Life Sci."},{"key":"10.1078\/0171-2985-00215_bib6","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)","volume":"87","author":"Mc Neil","year":"1990","journal-title":"Proc. Natl. Acad. Sci., USA"},{"key":"10.1078\/0171-2985-00215_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.179.2.457","article-title":"Anticardiolipin antibodies recognize Beta 2-Glicoprotein 1 structure altered by interacting with an oxygen modified solid phase surface","volume":"179","author":"Matsuura","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1078\/0171-2985-00215_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0897.1997.tb00198.x","article-title":"Phospholipid binding plasma proteins required for antiphospholipid antibody detection \u2013 an overview","volume":"37","author":"McIntyre","year":"1997","journal-title":"Am. J. Reprod. Immunol."},{"issue":"Suppl 2","key":"10.1078\/0171-2985-00215_bib9","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1177\/096120339800700208","article-title":"Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulant","volume":"7","author":"de Groot","year":"1998","journal-title":"Lupus"},{"issue":"Suppl 2","key":"10.1078\/0171-2985-00215_bib10","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1177\/096120339800700205","article-title":"Many faces of lupus anticoagulants","volume":"7","author":"Triplett","year":"1998","journal-title":"Lupus"},{"key":"10.1078\/0171-2985-00215_bib11","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/art.1780381016","article-title":"Causes of death in Systemic Lupus Erythematosus. Long-term followup of an inception cohort","volume":"38","author":"Ward","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1078\/0171-2985-00215_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am. J. Med."},{"key":"10.1078\/0171-2985-00215_bib13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with Systemic Lupus Erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"10.1078\/0171-2985-00215_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0002-9343(90)90368-N","article-title":"Association between antiphospholipid antibodies and cardiac abnormalities in patients with Systemic Lupus Erythematosus","volume":"89","author":"Leung","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1078\/0171-2985-00215_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D","article-title":"Prevalence and risk factors of carotid plaque in women with Systemic Lupus Erythematosus","volume":"42","author":"Manzi","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1078\/0171-2985-00215_bib16","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in Systemic Lupus Erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"key":"10.1078\/0171-2985-00215_bib17","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0002-9149(99)00130-7","article-title":"Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease","volume":"83","author":"Glueck","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1078\/0171-2985-00215_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2796.1995.tb01221.x","article-title":"Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease","volume":"238","author":"Nityanand","year":"1995","journal-title":"J. Intern. Med."},{"key":"10.1078\/0171-2985-00215_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1191\/0961203302lu165oa","article-title":"Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies","volume":"11","author":"Ames","year":"2002","journal-title":"Lupus"},{"key":"10.1078\/0171-2985-00215_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/ard.51.2.152","article-title":"Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus","volume":"51","author":"MacGregor","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1078\/0171-2985-00215_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/rheumatology\/39.4.353","article-title":"Systemic lupus erythematosus: a model for atherogenesis?","volume":"39","author":"Manzi","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1078\/0171-2985-00215_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/096120339700600610","article-title":"Dyslipoproteinemias in Systemic Lupus Erythematosus: influence of disease, activity, and anticardiolipin antibodies","volume":"6","author":"Borba","year":"1997","journal-title":"Lupus"},{"key":"10.1078\/0171-2985-00215_bib23","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.1780361111","article-title":"Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with Systemic Lupus Erythematosus","volume":"36","author":"Lahita","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1078\/0171-2985-00215_bib24","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.10542","article-title":"Antibodies towards High Density Lipoprotein and Beta-2-Glycoprotein-I are inversely correlated with Paraoxonase activity in Systemic Lupus Erythematosus (SLE) and Primary Antiphospholipid Syndrome (PAPS)","volume":"46","author":"Delgado","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1078\/0171-2985-00215_bib25","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/01.ATV.19.9.2214","article-title":"Human serum Paraoxonase\/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity","volume":"19","author":"Sorenson","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1078\/0171-2985-00215_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1078\/0171-2985-00215_bib27","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/blood.V97.8.2381","article-title":"Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes","volume":"97","author":"Hyka","year":"2001","journal-title":"Blood"},{"key":"10.1078\/0171-2985-00215_bib28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1191\/096120300677692516","article-title":"Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study","volume":"9","author":"Ames","year":"2000","journal-title":"Lupus"},{"key":"10.1078\/0171-2985-00215_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(95)02072-1","article-title":"The isoprostanes. Current knowledge and directions for future research","volume":"51","author":"Morrow","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1078\/0171-2985-00215_bib30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(94)92346-9","article-title":"The oxidation hypothesis of atherosclerosis","volume":"344","author":"Witztum","year":"1994","journal-title":"Lancet"},{"key":"10.1078\/0171-2985-00215_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-2952(99)00296-8","article-title":"Oxidative stress and nuclear factor-kappa \u03b2 activation: a reassessment of the evidence in the light of recent discoveries","volume":"59","author":"Bowie","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1078\/0171-2985-00215_bib32","doi-asserted-by":"crossref","first-page":"47632","DOI":"10.1074\/jbc.M108363200","article-title":"Thrombin stimulation of the vascular cell adhesion molecule-1 promoter in endothelial cells is mediated by tandem nuclear factor-Kappa B and GATA motifs","volume":"276","author":"Minami","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1078\/0171-2985-00215_bib33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.ATV.0000019009.73586.7F","article-title":"Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1","volume":"22","author":"Viedt","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1078\/0171-2985-00215_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/rheumatology\/38.6.529","article-title":"Oxidative stress in Systemic Lupus Erythematosus and allied conditions with vascular involvement","volume":"38","author":"Ames","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1078\/0171-2985-00215_bib35","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.ATV.17.7.1233","article-title":"Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis","volume":"17","author":"Mackness","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1078\/0171-2985-00215_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1078\/0171-2985-00215_bib37","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(98)05105-8","article-title":"Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation","volume":"353","author":"Mackness","year":"1999","journal-title":"Lancet"},{"key":"10.1078\/0171-2985-00215_bib38","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/01.ATV.20.9.2113","article-title":"Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients","volume":"20","author":"Tomas","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1078\/0171-2985-00215_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0021-9150(00)00680-8","article-title":"Relationship of agerelated myocardial infarction risk and Gln\/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study","volume":"156","author":"Senti","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1078\/0171-2985-00215_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1191\/096120300680198980","article-title":"Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies","volume":"9","author":"Lambert","year":"2000","journal-title":"Lupus"},{"key":"10.1078\/0171-2985-00215_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1191\/096120300678828280","article-title":"Antibodies to oxidised LDL","volume":"9","author":"Vaarala","year":"2000","journal-title":"Lupus"},{"key":"10.1078\/0171-2985-00215_bib42","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/01.CIR.103.7.941","article-title":"Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein","volume":"103","author":"Horkko","year":"2001","journal-title":"Circulation"},{"key":"10.1078\/0171-2985-00215_bib43","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1073\/pnas.97.4.1743","article-title":"Cardiolipin is a normal component of human plasma lipoproteins","volume":"97","author":"Deguchi","year":"2000","journal-title":"Proc. Natl. Acad. Sci., USA"},{"key":"10.1078\/0171-2985-00215_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/gepi.1370060202","article-title":"Phenotypic effects of apolipoprotein structural variation on lipid profiles. I. APO H and quantitative lipid measures in the healthy women study","volume":"6","author":"Eichner","year":"1989","journal-title":"Genet. Epidemiol."},{"key":"10.1078\/0171-2985-00215_bib45","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/hc3901.096667","article-title":"Highdensity lipoproteins and endothelial function","volume":"104","author":"O'Connell","year":"2001","journal-title":"Circulation"},{"key":"10.1078\/0171-2985-00215_bib46","first-page":"990","article-title":"Anti-apolipoprotein A-I autoantibody: characterization of monoclonal auto-Jose D. Alves, Paul R. J. Ames 28 antibodies from patients with Systemic Lupus Erythematosus","volume":"28","author":"Abe","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1078\/0171-2985-00215_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1191\/096120398678920262","article-title":"Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE","volume":"7","author":"Dinu","year":"1998","journal-title":"Lupus"},{"issue":"Suppl 1","key":"10.1078\/0171-2985-00215_bib48","first-page":"112","article-title":"Oxidative stress and small dense low-density lipoproteins (LDL) in systemic lupus erythematosus","volume":"40","author":"Nuttall","year":"2001","journal-title":"Rheumatology"},{"key":"10.1078\/0171-2985-00215_bib49","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1182\/blood.V93.10.3401.410k36_3401_3407","article-title":"Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation","volume":"93","author":"Pratico","year":"1999","journal-title":"Blood"},{"key":"10.1078\/0171-2985-00215_bib50","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","article-title":"Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype","volume":"44","author":"Meroni","year":"2001","journal-title":"Arthritis Rheum."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129850470159X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129850470159X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:18:31Z","timestamp":1759249111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S017129850470159X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003]]}},"alternative-id":["S017129850470159X"],"URL":"https:\/\/doi.org\/10.1078\/0171-2985-00215","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2003]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1078\/0171-2985-00215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Urban & Fischer Verlag. Published by Elsevier GmbH All rights reserved.","name":"copyright","label":"Copyright"}]}}